Survival curves determined by the Kaplan-Meier method for overall survival (OS) demonstrated that DR5 expression is not significantly associated with OS of CRC patients (p = 0.140) (Fig. 2B). This evidence concerns the gene TNFRSF10B and colorectal carcinoma.